• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妥布霉素滴眼液应用于胶原盾对实验性葡萄球菌性角膜炎的疗效。

Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.

作者信息

Callegan M C, Engel L S, Clinch T E, Hill J M, Kaufman H E, O'Callaghan R J

机构信息

Department of Microbiology, Immunology and Parasitology, Louisiana State University Medical Center School of Medicine, New Orleans 70112.

出版信息

Curr Eye Res. 1994 Dec;13(12):875-8. doi: 10.3109/02713689409015089.

DOI:10.3109/02713689409015089
PMID:7720394
Abstract

Treatment of staphylococcal keratitis includes tobramycin drops at repeated intervals, a prolonged therapy that is disruptive to the patient. To identify a regimen involving less frequent drug application, we compared the efficacy of fortified tobramycin (1.36%) administered by collagen shields or in topical drop form to rabbit corneas intrastromally infected with staphylococci. Eyes were treated with shields hydrated in and supplemented with fortified tobramycin drops (1.36%) applied every 1, 2, 5, or 10 h, from 10 to 20 h postinfection. For topical drop treatment alone, tobramycin was applied following the identical regimen. Untreated corneas contained 10(6) colony forming units. Shields supplemented with tobramycin drops applied every 1, 2, or 5 h sterilized 100% of the corneas. Shields supplemented with tobramycin drops applied at 10 h sterilized 58% of the corneas. Topical delivery of tobramycin every h sterilized all corneas; drops alone applied at longer intervals, such as 2, 5, or 10 h, sterilized 83%, 17%, and 0% of the corneas, respectively. Collagen shield delivery of tobramycin with supplemental topical drops can eradicate staphylococci in this model with less frequent dosing intervals than are required with topical therapy alone.

摘要

葡萄球菌性角膜炎的治疗包括反复使用妥布霉素滴眼液,这种长期治疗对患者来说很麻烦。为了确定一种用药频率较低的治疗方案,我们比较了通过胶原盾或局部滴眼形式给予的强化妥布霉素(1.36%)对感染葡萄球菌的兔角膜基质内注射的疗效。在感染后10至20小时,用在强化妥布霉素滴眼液(1.36%)中保湿并补充该滴眼液的胶原盾对眼睛进行治疗,每1、2、5或10小时给药一次。对于仅局部滴眼治疗,妥布霉素按照相同方案给药。未治疗的角膜含有10⁶个菌落形成单位。每1、2或5小时补充妥布霉素滴眼液的胶原盾使100%的角膜灭菌。每10小时补充妥布霉素滴眼液的胶原盾使58%的角膜灭菌。每小时局部给予妥布霉素使所有角膜灭菌;单独滴眼且给药间隔较长,如2、5或10小时,分别使83%、17%和0%的角膜灭菌。在该模型中,通过胶原盾给予妥布霉素并辅以局部滴眼,与单独局部治疗相比,给药间隔频率更低就能根除葡萄球菌。

相似文献

1
Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.妥布霉素滴眼液应用于胶原盾对实验性葡萄球菌性角膜炎的疗效。
Curr Eye Res. 1994 Dec;13(12):875-8. doi: 10.3109/02713689409015089.
2
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.环丙沙星与妥布霉素治疗葡萄球菌性角膜炎的对比研究
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1033-7.
3
Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.含妥布霉素的胶原盾用于实验性铜绿假单胞菌角膜炎的持续治疗(24小时)。
CLAO J. 1992 Oct;18(4):245-7.
4
Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.铜绿假单胞菌性角膜炎的角膜切开术模型:庆大霉素化疗
Refract Corneal Surg. 1992 Jan-Feb;8(1):39-43.
5
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.在葡萄球菌性和铜绿假单胞菌性角膜炎兔模型中,局部应用洗必泰、环丙沙星以及强化妥布霉素/头孢唑林的比较。
J Ocul Pharmacol Ther. 2007 Jun;23(3):213-20. doi: 10.1089/jop.2006.81.
6
Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits.妥布霉素浸润胶原盾与妥布霉素滴眼液负荷剂量对兔实验性铜绿假单胞菌性角膜炎持续治疗的疗效比较
Am J Ophthalmol. 1992 Apr 15;113(4):418-23. doi: 10.1016/s0002-9394(14)76165-3.
7
Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.在葡萄球菌和铜绿假单胞菌性角膜炎兔模型中,局部使用环丙沙星与局部使用强化抗生素的比较。
Cornea. 1993 Nov;12(6):517-21. doi: 10.1097/00003226-199311000-00010.
8
Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.评估角膜胶原盾作为治疗实验性铜绿假单胞菌角膜炎的药物递送装置。
Ophthalmology. 1992 Jun;99(6):889-92. doi: 10.1016/s0161-6420(92)31877-9.
9
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.在兔金黄色葡萄球菌角膜炎模型中,局部应用牛磺罗定与环丙沙星、氧氟沙星和强化头孢唑林的疗效比较。
Curr Eye Res. 2005 Mar;30(3):155-61. doi: 10.1080/02713680490908733.
10
Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.使用含妥布霉素的胶原盾治疗实验性铜绿假单胞菌角膜炎。
Arch Ophthalmol. 1988 Nov;106(11):1605-7. doi: 10.1001/archopht.1988.01060140773053.

引用本文的文献

1
Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.临床眼部肺炎链球菌菌株的发病机制及肺炎溶血素与角膜细胞的相互作用
J Bacteriol Parasitol. 2011;2(2):108. doi: 10.4172/2155-9597.1000108.
2
Treatment of ocular infections with topical antibacterials.局部应用抗菌药物治疗眼部感染。
Clin Pharmacokinet. 1999 Nov;37(5):351-60. doi: 10.2165/00003088-199937050-00001.